Medical Prophylaxis for the Post Myocardial Infarct Patient

  • Lawrence S. Cohen
    Corresponding Author: Section of Cardiology, 3 FMP Yale University School of Medicine 333 Cedar Street P.O. Box 3333 New Haven, CT 06510
    The Ebenezer K. Hunt Professor of Medicine, Yale University School of Medicine; and Attending Physician, Yale-New Haven Hospital, New Haven, Connecticut
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The use of β-adrenergic blocking drugs has been shown to benefit many post myocardial infarction patients. Aspirin is useful for secondary prevention and a subset of patients may benefit from short term anticoagulation
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Improvement in prognosis of myocardial infarction by long-term beta-adrenergic blockade using practolol.
        Br Med J. 1975; 3: 735
      2. Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction.
        JAMA. 1980; 243: 661
        • Baber N.S.
        • Evans D.W.
        • Howitt G.
        • et al.
        Multicenter post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia.
        Br Heart J. 1980; 44: 96
      3. β-Blocker Heart Attack Study Group: The 13-Blocker Heart Attack TrialThe β-Blocker Heart Attack Trial.
        JAMA. 1981; 246: 2073
        • Davis M.J.E.
        • Ireland M.A.
        Effect of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction.
        Am J Cardiol. 1986; 57: 1244
        • DeWood M.A.
        • Spores J.
        • Notske R.H.
        • et al.
        Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.
        N Engl J Med. 1980; 303: 897
        • DeWood M.A.
        • Stifter W.F.
        • Simpson C.S.
        • et al.
        Coronary arteriographic findings soon after non-Q-wave myocardial infarction.
        N Engl J Med. 1986; 315: 417
        • Elwood P.C.
        • Sweetnam P.M.
        Aspirin and secondary mortality after myocardial infarction.
        Circulation. 1980; 62: 53
        • Gibson R.S.
        • Boden W.E.
        • Theroux P.
        • et al.
        Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction Results of a double-blind, randomized, multicenter trial.
        N Engl J Med. 1986; 315: 423
        • May G.S.
        • Eberlein K.A.
        • Furberg C.D.
        • et al.
        Secondary prevention after myocardial infarction. A review of long-term trials.
        Prog Cardiovasc Dis. 1982; 24: 331
        • Meitzer R.S.
        • Visser C.A.
        • Fuster V.
        Intracardiac thrombi and systemic embolization.
        Ann Intern Med. 1986; 104: 689
      4. The Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of sudden death after myocardial infarction.
        N Engl J Med. 1980; 302: 250
      5. The Coronary Drug Project Research Group. Aspirin in coronary heart disease.
        J Chronic Dis. 1976; 29: 625
      6. The Norwegian Multicenter Study Group:Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.
        N Engl J Med. 1981; 304: 801
      7. The Persantine-Aspirin Reinfarction Study (PARIS) Research Group: The Persantin-Aspirin Reinfarction Study.
        . 1980; 62: 85